Cargando…
A protein domain-oriented approach to expand the opportunities of therapeutic exon skipping for USH2A-associated retinitis pigmentosa
Loss-of-function mutations in USH2A are among the most common causes of syndromic and non-syndromic retinitis pigmentosa (RP). We previously presented skipping of USH2A exon 13 as a promising treatment paradigm for USH2A-associated RP. However, RP-associated mutations are often private, and evenly d...
Autores principales: | Schellens, Renske T.W., Broekman, Sanne, Peters, Theo, Graave, Pam, Malinar, Lucija, Venselaar, Hanka, Kremer, Hannie, De Vrieze, Erik, Van Wijk, Erwin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258241/ https://www.ncbi.nlm.nih.gov/pubmed/37313440 http://dx.doi.org/10.1016/j.omtn.2023.05.020 |
Ejemplares similares
-
Zebrafish as a Model to Evaluate a CRISPR/Cas9-Based Exon Excision Approach as a Future Treatment Option for EYS-Associated Retinitis Pigmentosa
por: Schellens, Renske, et al.
Publicado: (2021) -
Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations
por: Dulla, Kalyan, et al.
Publicado: (2021) -
Molecular Inversion Probe-Based Sequencing of USH2A Exons and Splice Sites as a Cost-Effective Screening Tool in USH2 and arRP Cases
por: Reurink, Janine, et al.
Publicado: (2021) -
Scrutinizing pathogenicity of the USH2A c.2276 G > T; p.(Cys759Phe) variant
por: Reurink, Janine, et al.
Publicado: (2022) -
Generation and Characterization of a Zebrafish Model for ADGRV1-Associated Retinal Dysfunction Using CRISPR/Cas9 Genome Editing Technology
por: Stemerdink, Merel, et al.
Publicado: (2023)